Circulating hematopoietic progenitors in patients with primary lung cancer

Japanese Journal of Cancer Research : Gann
E ShimizuT Ogura

Abstract

The levels of circulating hematopoietic progenitors were measured in 28 patients with primary lung cancer. The average numbers of progenitors per milliliter of blood were 33 (range 0-360) for colony-forming unit-granulocyte macrophage (CFU-GM), 23 (range 0-140) for burst-forming unit-erythrocyte (BFU-E), and 4 (range 0-50) for colony-forming unit-mixed lineages (CFU-mix). No significant influence of age, sex, histological type, or clinical stage of the tumor on the progenitor levels was detected. After cytoreductive chemotherapy of the patients by treatment with cisplatin plus etoposide, the cells showed 6- to 50-fold rebound overshoots, but no rebound was observed after treatment with cisplatin alone, cisplatin plus mitomycin C or cisplatin plus vindesine plus mitomycin C, or in 4 of 5 patients treated with cyclophosphamide plus adriamycin plus vincristine. Peripheral blood hematopoietic progenitors should be useful as an alternative source of stem cells for lung cancer patients treated with marrow ablative chemotherapy.

References

Jan 1, 1989·Cancer Chemotherapy and Pharmacology·R L SouhamiJ S Tobias
Dec 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y HumbletJ Longueville
Oct 1, 1988·European Journal of Cancer & Clinical Oncology·J BenardG Riou
Feb 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SculierP Stryckmans
Oct 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D C IhdeR A Abrams
May 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D H JohnsonF A Greco
Jan 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G SpitzerD Chiuten
Jun 1, 1982·British Journal of Haematology·R D Barr, J A McBride
Jan 1, 1983·Cancer Chemotherapy and Pharmacology·R L SouhamiJ D Richards
Sep 1, 1983·International Journal of Cell Cloning·A RaghavacharI B Steinbach

❮ Previous
Next ❯

Citations

Nov 4, 1998·The Annals of Thoracic Surgery·F I HsuR J Downey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.